X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (21) 21
female (18) 18
male (17) 17
middle aged (17) 17
aged (16) 16
oncology (14) 14
adult (13) 13
index medicus (10) 10
cancer (8) 8
chemotherapy (8) 8
bevacizumab (7) 7
care and treatment (7) 7
metastasis (7) 7
survival analysis (7) 7
aged, 80 and over (6) 6
antineoplastic agents - therapeutic use (6) 6
treatment outcome (6) 6
analysis (5) 5
antineoplastic agents - adverse effects (5) 5
antineoplastic combined chemotherapy protocols - therapeutic use (5) 5
clinical trials (5) 5
disease-free survival (5) 5
leucovorin (5) 5
lung cancer (5) 5
medicine & public health (5) 5
research (5) 5
tumors (5) 5
urology & nephrology (5) 5
vascular endothelial growth factor (5) 5
angiogenesis inhibitors (4) 4
angiogenesis inhibitors - therapeutic use (4) 4
antibodies, monoclonal - administration & dosage (4) 4
antibodies, monoclonal - adverse effects (4) 4
antibodies, monoclonal - therapeutic use (4) 4
antibodies, monoclonal, humanized (4) 4
antimitotic agents (4) 4
antineoplastic agents (4) 4
apoptosis (4) 4
cancer research (4) 4
carboplatin (4) 4
carcinoma, renal cell (4) 4
carcinoma, renal cell - mortality (4) 4
carcinoma, renal cell - pathology (4) 4
colorectal neoplasms - drug therapy (4) 4
colorectal neoplasms - pathology (4) 4
dose-response relationship, drug (4) 4
immunotherapy (4) 4
kidney neoplasms - mortality (4) 4
kidney neoplasms - pathology (4) 4
lung cancer, non-small cell (4) 4
lung neoplasms - drug therapy (4) 4
medical colleges (4) 4
monoclonal antibodies (4) 4
neoplasm metastasis (4) 4
neoplasm staging (4) 4
phase-ii (4) 4
prognosis (4) 4
randomized controlled trials as topic (4) 4
retrospective studies (4) 4
therapy (4) 4
antineoplastic agents - administration & dosage (3) 3
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
cancer patients (3) 3
cancer therapies (3) 3
carcinoma (3) 3
carcinoma, non-small-cell lung - drug therapy (3) 3
carcinoma, renal cell - drug therapy (3) 3
carcinoma, renal cell - surgery (3) 3
cohort studies (3) 3
colorectal cancer (3) 3
colorectal neoplasms - mortality (3) 3
combination (3) 3
development and progression (3) 3
drug administration schedule (3) 3
drug therapy (3) 3
epidermal growth factor (3) 3
fluorouracil (3) 3
infusions, intravenous (3) 3
internal medicine (3) 3
kaplan-meier estimate (3) 3
kidney neoplasms - drug therapy (3) 3
kidney neoplasms - surgery (3) 3
medical research (3) 3
oncology, experimental (3) 3
taxoids - administration & dosage (3) 3
trial (3) 3
tyrosine (3) 3
abridged index medicus (2) 2
adolescent (2) 2
angiogenesis inhibitors - adverse effects (2) 2
animals (2) 2
antiangiogenesis (2) 2
article (2) 2
biologics (2) 2
breast neoplasms - drug therapy (2) 2
breast neoplasms - pathology (2) 2
carbonic anhydrases - biosynthesis (2) 2
carcinoma, non-small-cell lung - pathology (2) 2
cell line, tumor (2) 2
cell proliferation - drug effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2016, Volume 389, Issue 10066, pp. 255 - 265
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2010, Volume 11, Issue 7, pp. 619 - 626
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2018, Volume 379, Issue 23, pp. 2220 - 2229
Journal Article
Journal Article
Journal Article
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 3/2008, Volume 61, Issue 3, pp. 515 - 524
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 3/2014, Volume 140, Issue 3, pp. 443 - 452
Dichloroacetate (DCA) is a highly bioavailable small molecule that inhibits pyruvate dehydrogenase kinase, promoting glucose oxidation and reversing the... 
Dichloroacetate | Medicine & Public Health | Hematology | Non-small cell lung cancer | Oncology | Cancer Research | Internal Medicine | Cisplatin | APOPTOSIS | ACTIVATION | SENSITIVITY | GLYCOLYSIS | TRIAL | IN-VITRO | METABOLISM | ONCOLOGY | MITAPLATIN | AXIS | Lung Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - blood | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - pharmacokinetics | Lung Neoplasms - pathology | Male | Cisplatin - administration & dosage | Cell Hypoxia | Dichloroacetic Acid - blood | Treatment Failure | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Drug Administration Schedule | Administration, Oral | Carcinoma, Non-Small-Cell Lung - metabolism | Oxygen Consumption | Breast Neoplasms - drug therapy | Dichloroacetic Acid - administration & dosage | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Dichloroacetic Acid - pharmacokinetics | Cell Line, Tumor | Aged | Cell Proliferation - drug effects | Carcinoma, Non-Small-Cell Lung - drug therapy | Pulmonary embolism | Glucose metabolism | Medical colleges | Chemotherapy | Development and progression | Lung cancer, Small cell | Respiratory agents | Glucose | Lung cancer, Non-small cell | Dextrose | Tumors | Cancer | non-small cell lung cancer | cisplatin | dichloroacetate
Journal Article